VALOR-HCM: Novel Drug May Delay, Avert Invasive Therapy in O

A medical alternative to highly invasive septal reduction therapy for patients with obstructive hypertrophic cardiomyopathy and symptoms despite standard meds? Perhaps, a randomized trial suggests.

Related Keywords

Colorado , United States , Ohio , Tennessee , Washington , Vanderbilt University , John Cleveland , Milindy Desai , University Of Colorado , American College Of Cardiology , Cleveland Clinic , American College , Secondary Efficacy , Safety Endpoint Results ,